Sarepta Therapeutics (SRPT) Shares Outstanding (2010 - 2026)

Sarepta Therapeutics' Shares Outstanding (Entity) history runs 17 years deep, the most recent figure standing at $105.0 million for Q1 2026.

• In Q1 2026, Shares Outstanding (Entity) rose 7.83% year-over-year to $105.0 million; the TTM figure through Mar 2026 stood at $105.0 million (up 7.83% YoY), while the FY2025 annual figure was $100.1 million, up 5.31% from the prior year.
• Shares Outstanding (Entity) for Q1 2026 stood at $105.0 million, up from $100.1 million in the prior quarter.
• The five-year high for Shares Outstanding (Entity) was $105.4 million in Q3 2025, with the low at $87253.0 in Q1 2022.
• The 5-year median for Shares Outstanding (Entity) is $94.5 million (2024), against an average of $80.6 million.
• The sharpest annual moves came in 2022 and 2023: Shares Outstanding (Entity) sank 99.89% in 2022, then jumped 106647.05% in 2023.
• Sarepta Therapeutics' Shares Outstanding (Entity) stood at $88.0 million in 2022, then advanced by 6.57% to $93.7 million in 2023, then rose by 1.43% to $95.1 million in 2024, then rose by 5.31% to $100.1 million in 2025, then advanced by 4.86% to $105.0 million in 2026.
• Business Quant data shows SRPT's Shares Outstanding (Entity) at $105.0 million in Q1 2026, $100.1 million in Q4 2025, and $105.4 million in Q3 2025.